ICYMI: Our Privilege
Editor's note: This was originally published May 11, 2020 and is being shared again this week in case you missed it.
Editor's note: This was originally published May 11, 2020 and is being shared again this week in case you missed it.
Editor's note: This article was originally published May 7, 2020 and is being shared again this week in case you missed it.
Editor's note: This article was originally published May 18, 2020, and is being shared again this week in case you missed it.
Editor's note: This blog was originally published April 16, 2020, and is being shared again this week in case you missed it.
Editor's note: This blog was originally published March 31, 2020 and is being shared again in case you missed it.
Editor's note: This news item was originally published May 21,2020, and is being shared again this week in case you missed it.
Two recent reports further characterize the newly described, Kawasaki-like, syndrome affecting children with COVID-19 infections.
A retrospective, observational study published in Lancet Rheumatology has shown that tocilizumab (TCZ) may reduce the risk of death or the need for mechanical ventilation in severe COVID-19 pneumonia.
Dr Jack Cush reviews the news and journal articles from the past week on RheumNow.com
Colchicine has been advocated as a potential antiinflammatory intervention in patients with the coronavirus 2 infection and clinical trials have been developed to assess its effect in early COVID-2 infection. JAMA has published a randomized clinical trial showing that low dose colchici
You’ve heard it said that if you don’t care for yourself, you cannot truly care for others. For many, this can be a hard pill to swallow. Too often we put ourselves last in the line up of importance.
Add this to the list of hydroxychloroquine (HCQ) letdowns in managing COVID-19 treatment or risk - prophylaxis with HCQ fails to prevent COVID-19 infection in those exposed to the SARS-CoV-2 virus.
Links:
Links:
Links:
Janet Pope @Janetbirdope ( View Tweet )